Physician profile
James R Colvert
NPI 1194727461
$5,454.32
in general payments reported to CMS, 2019-2025
36 companies · $658 in 2025
The $658 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $734 · 2021: $1,391 · 2022: $879 · 2023: $914 · 2024: $472 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,996 · Education: $47.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,996.45 |
| Education | $47.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $885.63 | 2019-2025 | Xtandi |
| Coloplast Corp | $584.28 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $546.68 | 2020-2025 | Myrisk, Prolaris |
| Axonics, INC. | $361.60 | 2020-2023 | Axonics |
| Healthtronics Stone Solutions, LLC | $330.44 | 2019-2021 | |
| Teleflex LLC | $272.75 | 2021-2024 | Urolift |
| Sumitomo Pharma America, INC. | $248.10 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $239.71 | 2019-2025 | Lupron Depot |
| Pfizer INC. | $233.56 | 2019-2025 | |
| Boston Scientific Corporation | $222.21 | 2019-2024 | Lithovue, Ams 700 Cxr Rte Kit, Ams 700 |
| Medtronic, INC. | $190.18 | 2023-2025 | Interstim |
| Neotract INC. | $186.34 | 2019-2020 | |
| Accord Healthcare, INC. | $148.44 | 2023-2025 | |
| Procept Biorobotics Corporation | $145.22 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $113.56 | 2019-2023 | Xiaflex, Aveed |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $107.26 | 2021-2022 | |
| Myovant Sciences INC. | $102.00 | 2021 | |
| Verity Pharmaceuticals INC. | $80.11 | 2024 | Trelstar |
| Ambu INC. | $52.50 | 2020 | |
| Clarus Therapeutics INC. | $44.54 | 2021 | |
| Urogen Pharma, INC. | $39.56 | 2023-2025 | Jelmyto |
| Travere Therapeutics, INC. | $34.01 | 2019-2020 | |
| Laborie Medical Technologies Corp. | $33.16 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Janssen Biotech, INC. | $28.41 | 2021 | |
| Convatec INC. | $27.26 | 2023 | |
| Innovation Technologies INC | $26.69 | 2023 | Irrisept |
| Allergan, INC. | $24.27 | 2020-2021 | |
| Tolmar Pharmaceuticals, INC. | $20.66 | 2021 | |
| Progenics Pharmaceuticals, INC. | $17.32 | 2023 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $16.88 | 2025 | |
| Hollister Incorporated | $16.41 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.41 | 2025 | Adstiladrin |
| Clovis Oncology, INC. | $15.22 | 2020 | |
| Novo Nordisk INC | $14.82 | 2023 | |
| Immunitybio, INC. | $14.75 | 2024 | |
| Antares Pharma, INC. | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Colvert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.